4VI Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Genomtec SA

Watchlist Manager

Watchlist

Price: 0.642 EUR -4.18% Market Closed

Market Cap: €8.6m

G	Genomtec SA F:4VI	PL
P	Petroleo Brasileiro SA Petrobras DUS:PJXB	BR
	Location Based Technologies Inc OTC:LBAS	US

Profitability Summary

Genomtec SA's profitability score is 10/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Negative Gross Margin

-33 577%

Negative 3Y Average Gross Margin

-117 082%

Declining Gross Margin

-2 240% > -33 577%

Negative Operating Margin

-36 818%

Negative 3Y Average Operating Margin

-478 043%

Declining Operating Margin

-13 635% > -36 818%

Negative Net Margin

-37 650%

Negative 3Y Average Net Margin

-488 546%

Declining Net Margin

-14 153% > -37 650%

Negative Free Cash Flow Margin

-44 482%

Negative 3Y Average Free Cash Flow Margin

-379 986%

Declining Free Cash Flow Margin

-10 522% > -44 482%

Negative ROE

-75%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-121%

ROIC is Increasing

-186% > -84%

View All

Hide

Collapse

10 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.